New Product/Service Testing

[ad_1] BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for…

[ad_1] An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said,…

[ad_1] To the Editor: Pfizer has a lot of good and bad points, as mentioned in your cover story “Pfizer…

[ad_1] Moderna stock jumped by double digits Tuesday on positive news about the company’s cancer vaccine, but Chardan Capital Markets…